BRIEF published on 07/17/2025 at 07:04, 9 months 21 days ago Medartis Finalizes Full Acquisition of KeriMedical FDA Approval Medartis Acquisition KeriMedical Joint Replacement TOUCH Prosthesis
PRESS RELEASE published on 07/17/2025 at 06:59, 9 months 21 days ago Medartis acquires remaining 53% stake in KeriMedical Medartis acquires remaining 53% stake in KeriMedical, strengthening position in joint replacement & expanding surgeon network. Acquisition valued at CHF 99 million in cash with FDA-approved flagship product TOUCH Acquisition FDA Approval Medartis KeriMedical Joint Replacement
PRESS RELEASE published on 03/18/2025 at 06:59, 1 year 1 month ago Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA margin from 17% to 19%
PRESS RELEASE published on 08/20/2024 at 07:05, 1 year 8 months ago Medartis reports 13% revenue growth on Group level, driven by strong regional growth in the US (21%) and EMEA (18%) –improvement of EBITDA* margin to 17%
BRIEF published on 07/09/2024 at 07:04, 1 year 9 months ago Matthias Schupp Appointed as CEO of Medartis Medical Technology CEO Appointment Medartis Matthias Schupp
PRESS RELEASE published on 07/09/2024 at 06:59, 1 year 9 months ago Basel, 9th July 2024 Matthias Schupp appointed as CEO of Medartis Medartis appoints Matthias Schupp as CEO, succeeding Christoph Brönnimann. Schupp brings extensive experience in the medical technology sector CEO Appointment Leadership Transition Medartis Matthias Schupp Medical Technology Sector
BRIEF published on 06/11/2024 at 07:04, 1 year 10 months ago Medartis Announces Resignation of CEO Christoph Brönnimann Corporate Leadership CEO Resignation Business Transition Medartis Christoph Brönnimann
PRESS RELEASE published on 06/11/2024 at 06:59, 1 year 10 months ago Basel, 11th June 2024 Medartis announces resignation of CEO Christoph Brönnimann Medartis Holding AG announces resignation of CEO Christoph Brönnimann. The Board initiates search for successor to ensure smooth transition and future growth Resignation CEO Successor Transition Medartis Holding AG
BRIEF published on 04/04/2024 at 07:30, 2 years 1 month ago Medartis Holding AG Successfully Places CHF 115.8 Million in Convertible Bonds Convertible Bonds Financial Strategy Medartis Holding AG Orthopaedic Surgery Investor Base Expansion
PRESS RELEASE published on 04/04/2024 at 07:25, 2 years 1 month ago Medartis successfully places CHF 115.8 million convertible bonds due 2031 Medartis Holding AG successfully completes CHF 115.8 million convertible bond placement due 2031 for strategic business expansion and acquisitions. CFO Dirk Kirsten highlights growth opportunities Convertible Bonds Business Expansion Medartis Holding AG Funding Purposes Dirk Kirsten
Published on 05/07/2026 at 05:40, 2 hours 19 minutes ago New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 5 hours 59 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 8 hours 29 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 8 hours 54 minutes ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 8 hours 59 minutes ago Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/07/2026 at 07:35, 23 minutes ago Rare Watches Spark Frenzied Interest in FutureGrail's May Auction
Published on 05/07/2026 at 07:35, 24 minutes ago Lenzing delivers positive net result in Q1 2026 and significantly increases free cash flow
Published on 05/07/2026 at 07:31, 27 minutes ago Henkel delivers good organic sales growth in the first quarter of 2026
Published on 05/07/2026 at 07:30, 28 minutes ago Q1 2026: Solid start to the year confirms transformation strategy
Published on 05/07/2026 at 07:30, 28 minutes ago SGL Carbon: Expected lower sales, but EBITDA margin improved. Forecast confirmed
Published on 05/06/2026 at 18:00, 13 hours 58 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 13 hours 59 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 17:45, 14 hours 14 minutes ago Information concerning the total number of voting rights and shares 2026 04 30
Published on 05/06/2026 at 17:45, 14 hours 14 minutes ago Declaration of voting rights at the end of April 2026
